Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application
Most anticancer agents exhibit a narrow therapeutic index, i.e., a small change in plasma concentrations can lead to a less efficacious treatment or an unacceptable degree of toxicity. This study aimed at providing health professionals with a feasible and time-saving tool to adapt the dose of antica...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Österreichische Apotheker-Verlagsgesellschaft m. b. H.
2017-02-01
|
Series: | Scientia Pharmaceutica |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-0532/85/1/8 |